Back to Search
ROCCO DIPAOLA, MD
MD
Specialist
NPI: 1285692053IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
25MA06405200(NJ)
CMS Specialties
PrimaryNEUROLOGY
Education
RUTGERS NEW JERSEY MEDICAL SCHOOL
Class of 1991
Research & Publications (20)
Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy.
PMID 18767033·Prostate·2008
8-other
A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer.
PMID 16390546·J Transl Med·2006
8-other
Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies.
PMID 12601301·Med Sci Monit·2003
3-trial
Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancer.
PMID 11919247·J Clin Oncol·2002
3-trial
State-of-the-art prostate cancer treatment and research. A report from the Cancer Institute of New Jersey.
PMID 11221439·N J Med·2001
4-observational
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.
PMID 11596021·Cancer·2001
3-trial
Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology Group.
PMID 19536901·Cancer·2009
3-trial
Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer.
PMID 19087985·Ann Oncol·2009
3-trial
Synthesis and stereochemical preference of peptide 4-aminocyclophosphamide conjugates as potential prodrugs of phosphoramide mustard for activation by prostate-specific antigen (PSA).
PMID 19345094·Bioorg Med Chem Lett·2009
8-other
Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
PMID 19380444·J Clin Oncol·2009
3-trial
Survival following primary androgen deprivation therapy among men with localized prostate cancer.
PMID 18612114·JAMA·2008
4-observational
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
PMID 17437819·J Urol·2007
3-trial
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference.
PMID 17644118·J Urol·2007
8-other
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer.
PMID 17822457·BJU Int·2007
3-trial
Bacillus Calmette-Guerin mechanism of action: the role of immunity, apoptosis, necrosis and autophagy.
PMID 17868741·J Urol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 633 RTE 37 W
TOMS RIVER, NJ 08755 - Phone
- (732) 240-4787
Quick Facts
- NPI
- 1285692053
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile